COR
Cencora Inc.
NYSE: COR · HEALTHCARE · MEDICAL DISTRIBUTION
$324.35
-0.31% today
Updated 2026-10-28
Market cap
$65.06B
P/E ratio
25.31
P/S ratio
0.20x
EPS (TTM)
$13.47
Dividend yield
0.69%
52W range
$244 – $375
Volume
1.2M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
6.7
Growth
B5.0
Quality
C+6.0
Profitability
B5.3
Valuation
C+4/9
Piotroski F-Score
Moderate
4.4
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$395.23
+21.85%
12-Month target
$286.54
-11.66%
Intrinsic (DCF)
$190.32
Margin of safety
-70.42%
4 Strong Buy7 Buy3 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 4.36 — safe zone
+ ROE 86.03% — strong efficiency
+ Free cash flow $2.43B — positive
Risks
- Thin margins at 0.79%
- 70.42% above intrinsic value
- Debt/equity 3.84x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $238.59B | $262.17B | $293.96B | $321.33B | $332.77B | $350.0B |
| Net income | $1.70B | $1.75B | $1.51B | $1.55B | $763.52M | — |
| EPS | — | — | — | — | $13.47 | $17.80 |
| Free cash flow | $2.21B | $3.45B | $3.00B | $3.21B | $2.43B | — |
| Profit margin | 0.71% | 0.67% | 0.51% | 0.48% | 0.79% | — |
Peer comparison
Smart narrative
Cencora Inc. trades at $324.35. representing a P/E of 25.31x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 4.36, it sits in the safe zone. TTM revenue stands at $332.77B. with profit margins at 0.79%. Our DCF model estimates intrinsic value at $190.32.
Frequently asked questions
What is Cencora Inc.'s stock price?
Cencora Inc. (COR) trades at $324.35, on a P/E of 25.3x and a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Cencora Inc. overvalued?
Cencora Inc. carries a Smart Value Score of 62/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $190.32 against the $324.35 price, so on cash flow terms the market is paying a premium for Cencora Inc.'s growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Cencora Inc. (COR)?
The 12-month analyst consensus target is $395.23, about 21.9% above the current $324.35. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of COR by 2030?
Our research-backed model puts the 2030 base case at $318.82, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Cencora Inc. (COR)?
Our DCF model estimates intrinsic value at $190.32, a -70.4% margin of safety versus today's $324.35. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Cencora Inc.'s revenue?
Cencora Inc.'s trailing twelve-month revenue is $332.77B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Cencora Inc.'s Altman Z-Score is 4.36, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.20x
ROE86.03%
Beta0.58
50D MA$320.25
200D MA$317.48
Shares out0.19B
Float0.18B
Short ratio—
Avg volume1.2M
Performance
1 week-4.42%
1 month+7.10%
3 months+2.12%
YTD-3.67%
1 year-3.06%
3 years—
5 years—